Novartis Ag NVS
NYSE NVS
$159.96 -3.33 (-2.04%)
As of: Nov 11, 2026 · 9:57 AM EST

Novartis Ag (NVS) Capital Leases (2019 - 2023)

Updated

Novartis Ag's Capital Leases was $230 million in Q4 2023, down 8.4% from $251 million a year earlier.

Analysis

Novartis Ag (NVS) Capital Leases (2019 - 2023) Analysis & Trends

From Q4 2019 onward, Novartis Ag has reported Capital Leases for 5 quarters.

  • Capital Leases has now declined for three consecutive years, with a four-year compound annual growth rate of -1.7% (FY2019 to FY2023).
  • In earlier years, Capital Leases was $251 million in FY2022 (-8.7%), $275 million in FY2021 (-3.8%), $286 million in FY2020 (+16.3%) and $246 million in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Vertex Pharmaceuticals 138.90 Bn 106.64 Bn 2.91 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 230.00 Mn
Dec 31, 2022 251.00 Mn
Dec 31, 2021 275.00 Mn
Dec 31, 2020 286.00 Mn
Dec 31, 2019 246.00 Mn
API Access

Novartis Ag Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=NVS&period=max&api_key=YOUR_API_KEY